IBM's application uses a combination of Watson's cognitive system, deep computational biology models and IBM's public cloud infrastructure, SoftLayer. Watson is designed to continually "learn" as it encounters new patient scenarios, medical studies, and genomic and drug information.
"Using Watson's cognitive computing capabilities, Cleveland Clinic aims to offer cutting-edge care to millions of patients," said Merkel said Wednesday. "We're excited by our continued partnership with Cleveland Clinic. Together we aim to advance a new era of cognitive computing that will aide in the acceleration of new discoveries and bring forward new breakthroughs in personalized medicine."
According to IBM, the Watson-based cloud service is able to focus on identifying patterns in genome sequencing and link that information to medical data to reveal insights that might help oncologists develop treatments that will work specifically with a patient's DNA.
This new cloud-based research pilot is the next step in an ongoing program IBM has with the Cleveland Clinic to advance the use of big data in healthcare.
Sign up for CIO Asia eNewsletters.